Savara (SVRA) Debt Ratio (2015 - 2026)
Savara (SVRA) posted quarterly Debt Ratio of 0.14 for Q1 2026, down 13.02% year-over-year from 0.16 in Q1 2025, and up 14.95% quarter-over-quarter from 0.12 in Q4 2025.
Savara (SVRA) Debt Ratio (2015 - 2026) Analysis & Trends
Savara (SVRA) has reported Debt Ratio for 12 consecutive years, with 0.14 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio fell 13.02% year-over-year to 0.14; the TTM figure through Mar 2026 stood at 0.14 (down 13.02% YoY), while the FY2025 annual figure was 0.12, down 5.63% from the prior year.
- Debt Ratio advanced to 0.14 in Q1 2026 per SVRA's latest filing, from 0.12 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.22 in Q2 2023 and bottomed at 0.11 in Q3 2024.
- Historically, Debt Ratio has averaged 0.16 across 5 years, with a median of 0.17 in 2022.
- Annual changes were most pronounced in 2024 — Debt Ratio slipped 22.97% — and 2025, when it soared 90.07%.
- Savara's Debt Ratio stood at 0.19 in 2022, then fell by 20.47% to 0.15 in 2023, then retreated by 15.73% to 0.13 in 2024, then slipped by 5.63% to 0.12 in 2025, then gained by 14.95% to 0.14 in 2026.
- Business Quant data shows SVRA's Debt Ratio at 0.14 in Q1 2026, 0.12 in Q4 2025, and 0.21 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Savara | 1.11 Bn | 1.11 Bn | - | 0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.16 |
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.12 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.18 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.20 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.17 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.14 |